Skip to content

Clinical trials

Phase 4 Lymphoma, Large B-Cell, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 4 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20141
20161
20172
20181
20211
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status5
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mingzhi Zhang3
Chongqing University Cancer Hospital1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Millennium Pharmaceuticals, Inc.1
PETHEMA Foundation1
Ruijin Hospital1
The First Hospital of Jilin University1
University of Maryland, Baltimore1
Vanderbilt-Ingram Cancer Center1
Zhengzhou University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse12
Recurrence3
Burkitt Lymphoma2
Hodgkin Disease2
Lymphoma2
Anemia1
Blast Crisis1
Dendritic Cell Sarcoma, Interdigitating1
Graft vs Host Disease1
HIV Infections1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.